Total planned funding: $97,720,583
Allocations
Countries/Regions
India | $97,720,583 |
Organizational Types
Unknown | $29,858,000 |
NGO | $29,478,454 |
Own Agency | $18,904,640 |
University | $8,490,217 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
FBO | $2,000,000 |
Multi-lateral Agency | $1,350,000 |
Host Country Government Agency | $1,200,000 |
Program Areas
Governance and Systems | $46,456,906 |
Prevention | $20,433,542 |
Management and Operations | $14,596,324 |
Care | $10,355,668 |
Treatment | $3,235,306 |
Testing | $2,642,837 |
Budget Codes
OHSS: Health Systems Strengthening | $28,184,996 |
HVMS: Management and Operations | $14,596,324 |
HVSI: Strategic Information | $12,856,506 |
HVOP: Sexual Prevention: Other Sexual Prevention | $11,984,310 |
HLAB: Laboratory Infrastructure | $5,415,404 |
HBHC: Care: Adult Care and Support | $5,065,921 |
HTXS: Treatment: Adult Treatment | $2,643,765 |
HVCT: Testing: HIV Testing and Counseling | $2,642,837 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,562,875 |
HVTB: Care: TB/HIV | $2,528,397 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,380,928 |
HKID: Care: Orphans and Vulnerable Children | $2,368,604 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,635,593 |
PDTX: Treatment: Pediatric Treatment | $568,064 |
PDCS: Care: Pediatric Care and Support | $392,746 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$29,858,000
Countries/Regions
USG Aggregated Agencies:
$12,911,741
Countries/Regions
FHI 360:
$7,900,954
Countries/Regions
Voluntary Health Services:
$6,160,000
Countries/Regions